C4 to launch Austrian Early stage fund

Austrian C4 Private Equity GmbH has announced plans to launch an Austria-based biotechnology fund under the name C4 Early Stage Fund 2. The fund aims to raise E30-40m to invest in up to ten Austrian early-stage businesses in the biotechnology and medical technology sectors. The fund aims to return 15 - 20% in value annually to shareholders.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH